Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2023-2030
The Specialty Drug Distribution Market is projected to reach USD 11.40 billion by 2030 from USD 3.83 billion in 2022, at a CAGR of 14.60% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Specialty Drug Distribution Market.
- Based on Disease Indication, market is studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis. The Oncology commanded largest market share of 24.76% in 2022, followed by Rheumatoid Arthritis.
- Based on Distributor Type, market is studied across Full line Wholesalers and Specialty Distributors. The Full line Wholesalers commanded largest market share of 55.46% in 2022, followed by Specialty Distributors.
- Based on Distribution Type, market is studied across Hospitals & Clinic Pharmacies, Independent Pharmacies, Large Chain Pharmacies, Mail-Order Pharmacies, Online Stores, and Specialty Pharmacies. The Hospitals & Clinic Pharmacies commanded largest market share of 36.31% in 2022, followed by Large Chain Pharmacies.
- Based on End-User, market is studied across Ambulatory Surgical Centers, Healthcare Payers, Home Settings, and Hospital & Clinics. The Hospital & Clinics commanded largest market share of 42.56% in 2022, followed by Healthcare Payers.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 43.52% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Specialty Drug Distribution Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Specialty Drug Distribution Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Specialty Drug Distribution Market, highlighting leading vendors and their innovative profiles. These include Aark Pharmaceuticals, Accredo Health Group, Inc., AmerisourceBergen Corporation, BioCare, Inc., Cardinal Health, Inc., Centene Corporation, China National Pharmaceutical Group Corporation, CVS Specialty, Inc., Elevance Health, Inc., Eversana, Feron Healthcare Pvt Ltd., Kroger Specialty Pharmacy, Lifeline Pharmaceuticals, LLC, McKesson Corporation, Medipal Holdings Corporation, Morris & Dickson Co., LLC, Optum, Inc., PHOENIX Pharmahandel GmbH & Co KG, Shanghai Pharmaceuticals Group Co., Ltd., Shields Health Solutions Holdings, LLC, Sun Pharmaceutical Industries Limited, Suzuken Co., Ltd., Teva Pharmaceutical Industries Ltd., and Walmart Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Specialty Drug Distribution Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Specialty Drug Distribution Market?
- What is the competitive strategic window for identifying opportunities in the Specialty Drug Distribution Market?
- What are the latest technology trends and regulatory frameworks in the Specialty Drug Distribution Market?
- What is the market share of the leading vendors in the Specialty Drug Distribution Market?
- Which modes and strategic moves are suitable for entering the Specialty Drug Distribution Market?
Please Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Specialty Drug Distribution Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing specialty drug development pipeline and trade
- 5.1.1.2. Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
- 5.1.2. Restraints
- 5.1.2.1. Complexity in managing different distribution channels
- 5.1.3. Opportunities
- 5.1.3.1. New technology integration and advancements in specialty drug distribution
- 5.1.3.2. Rising expansion of specialty pharmacies worldwide
- 5.1.4. Challenges
- 5.1.4.1. Changing regulatory frameworks associated with specialty drug handling
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.3.1. Introduction of new digital ecosystems focusing on improving the distribution of specialty drugs in the Americas
- 5.3.2. Focus on specialty drug distribution network expansion in the Asia-Pacific region
- 5.3.3. Government initiatives for rare disease management and well-established pharma companies expand the market growth
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 5.10.1. Clinical Trials & Drug Development Pipeline
- 5.10.2. Speciality Drug Distribution Ecosystem
- 6. Specialty Drug Distribution Market, by Disease Indication
- 6.1. Introduction
- 6.2. AIDS
- 6.3. Hemophilia
- 6.4. Multiple Sclerosis
- 6.5. Oncology
- 6.6. Rheumatoid Arthritis
- 7. Specialty Drug Distribution Market, by Distributor Type
- 7.1. Introduction
- 7.2. Full line Wholesalers
- 7.3. Specialty Distributors
- 8. Specialty Drug Distribution Market, by Distribution Type
- 8.1. Introduction
- 8.2. Hospitals & Clinic Pharmacies
- 8.3. Independent Pharmacies
- 8.4. Large Chain Pharmacies
- 8.5. Mail-Order Pharmacies
- 8.6. Online Stores
- 8.7. Specialty Pharmacies
- 9. Specialty Drug Distribution Market, by End-User
- 9.1. Introduction
- 9.2. Ambulatory Surgical Centers
- 9.3. Healthcare Payers
- 9.4. Home Settings
- 9.5. Hospital & Clinics
- 10. Americas Specialty Drug Distribution Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Specialty Drug Distribution Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Specialty Drug Distribution Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. Merger & Acquisition
- 13.3.1.1. Elevance Health Announces Closing of BioPlus Acquisition
- 13.3.1.2. CVS Health to acquire Oak Street Health
- 13.3.1.3. Prime Therapeutics closes USD 1.35 billion Magellan Rx acquisition, uniting pharmacy and medical drug management expertise
- 13.3.1.4. Halozyme to Acquire Antares Pharma for around USD 960 million
- 13.3.2. Agreement, Collaboration, & Partnership
- 13.3.2.1. Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
- 13.3.2.2. Shields Health Solutions and MyMichigan Health Partner to Enhance Specialty Pharmacy Services for Patients and Families
- 13.3.2.3. Shields Health Solutions Expands Nationwide Partnerships to Enhance Specialty Pharmacy Services
- 13.3.2.4. Manulife and Shoppers Drug Mart collaborate to help manage serious medical conditions
- 13.3.3. New Product Launch & Enhancement
- 13.3.3.1. McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes
- 13.3.4. Award, Recognition, & Expansion
- 13.3.4.1. Cardinal Health Continues to Expand at-Home Solutions Business
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Aark Pharmaceuticals
- 14.1.2. Accredo Health Group, Inc.
- 14.1.3. AmerisourceBergen Corporation
- 14.1.4. BioCare, Inc.
- 14.1.5. Cardinal Health, Inc.
- 14.1.6. Centene Corporation
- 14.1.7. China National Pharmaceutical Group Corporation
- 14.1.8. CVS Specialty, Inc.
- 14.1.9. Elevance Health, Inc.
- 14.1.10. Eversana
- 14.1.11. Feron Healthcare Pvt Ltd.
- 14.1.12. Kroger Specialty Pharmacy
- 14.1.13. Lifeline Pharmaceuticals, LLC
- 14.1.14. McKesson Corporation
- 14.1.15. Medipal Holdings Corporation
- 14.1.16. Morris & Dickson Co., LLC
- 14.1.17. Optum, Inc.
- 14.1.18. PHOENIX Pharmahandel GmbH & Co KG
- 14.1.19. Shanghai Pharmaceuticals Group Co., Ltd.
- 14.1.20. Shields Health Solutions Holdings, LLC
- 14.1.21. Sun Pharmaceutical Industries Limited
- 14.1.22. Suzuken Co., Ltd.
- 14.1.23. Teva Pharmaceutical Industries Ltd.
- 14.1.24. Walmart Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook